The researchers used electronic health record data from OneFlorida+ a health research network that includes 10 health systems and clinical partners that serve nearly 20 million patients in Florida, Georgia and Alabama to identify adults who were eligible for anti-obesity medications and had no cancer history
and Davies, M., 2023
Rather than assuming all patients experience side effects equally, PlexusDx helps bridge the gap between genetic predisposition and clinical practice, enabling discussions about tailored dosing, formulation choice, and escalation speed based on your unique biology
If you need the most aggressive weight loss intervention available, retatrutide is it
Direct medication costs The medication itself runs $450 to $750 per month depending on your dose level and source
The SUPRPASS-4 trial (262), involving 2002 participants with high-risk cardiovascular profiles followed for up to 104 weeks, showed no difference in 4-MACE events (cardiovascular death, myocardial infarction, stroke, and hospitalization for unstable angina) with tirzepatide compared to insulin glargine (HR 0.74